Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Margin

    Back to All Ratios
LYKA LABS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 14.1318.0952.1222.82-5.97

What is the latest Core EBITDA Margin ratio of LYKA LABS ?

The latest Core EBITDA Margin ratio of LYKA LABS is 14.13 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202414.13
Mar202318.09
Mar202252.12
Mar202122.82
Mar2020-5.97

How is Core EBITDA Margin of LYKA LABS Trending?

Years Core EBITDA Margin % Change
Mar2024 14.13
-21.89
Mar2023 18.09
-65.29
Mar2022 52.12
128.40
Mar2021 22.82
Positive
Mar2020 -5.97 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Margin ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹433.0 Cr 3.9% 9.4% 13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,680.0 Cr 0.2% -8.3% 15.9% Stock Analytics
DIVIS LABORATORIES ₹175,532.0 Cr -1.9% 8.6% 55.9% Stock Analytics
CIPLA ₹118,315.0 Cr -1.3% -5.5% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,421.0 Cr -0.5% -4.2% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,453.0 Cr 0.7% 5.8% 6.1% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

3.9%

9.4%

13.6%

SENSEX

-0.3%

1.5%

8%


You may also like the below Video Courses